Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients with pathologically confirmed colorectal cancer~2. Signed consent~Exclusion Criteria:~1. Tumor can be resected by endoscopic mucosal resection(EMR)~2. History of malignancy~3. Bowel obstruction or intestinal perforation~4. Evidence of metastasis by physical examination, chest roentgenogram and computed tomography of liver and pelvis~5. Acute diseases and acute attack of chronic diseases~6. Psychiatric history~7. Deformity of spine~8. ASA score≥Ⅳ~9. Mid-low rectal cancer~10. Pregnant woman~11. Needing to use Chinese traditional patent drug

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Conventional Treatment （Laparoscopic） (Type: ACTIVE_COMPARATOR): Randomized group of patients receiving laparoscopic colectomy with conventional perioperative treatment and mFolfox6 chemotherapy.
- FTMD Treatment （Laparoscopic） (Type: ACTIVE_COMPARATOR): Randomized group of patients receiving laparoscopic colectomy with Fast Track Multi-Displine（FTMD）treatment and XELOX chemotherapy.
- Conventional Treatment（Open Surgery） (Type: ACTIVE_COMPARATOR): Randomized group of patients receiving open colectomy with conventional perioperative treatment and mFolfox6 chemotherapy.
- FTMD Treatment（Open Surgery） (Type: ACTIVE_COMPARATOR): Randomized group of patients receiving open colectomy with Fast Track Multi-Displine（FTMD） treatment and XELOX chemotherapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).